Drivers of substandard and falsified medicines

Blue skies thinking on viral elimination strategies

Detecting, Investigating, and Responding to HIV Transmission Clusters

  1. Addressing the Nexus of Risk Behavior and Gender Inequalities in the Continuum of Care Model for Women
  2. Implementation Science of the Women's Health Co-Op in Clinical Care settings: Challenges and Barriers

Wendee M. Wechsberg, PhD, is the Director of the Substance Use, Gender, and Applied Research Program and Founding Director of the RTI Global Gender Center at RTI International. She is also Adjunct Professor at three local universities. Since 1994, Dr. Wechsberg has devoted her career to developing and testing the efficacy of gender-focused HIV prevention interventions. Dr. Wechsberg is the developer of the Women's CoOp, a woman-focused HIV prevention program that has been adapted globally. Dr. Wechsberg's most recent book is HIV Pioneers, due out this summer.

César Núñez, MD, MPH

 

Dr César Núñez leads the UNAIDS Latin American & Caribbean Regional Support Team which supports countries to  deliver on the Fast Track agenda to end AIDS by 2030 as part of the Sustainable Development Goals.

Dr Núñez has close to 30 years of public service. Before moving to international development at US government funded projects and the United Nations, he worked to improve the health and welfare of vulnerable communities in his native Honduras. 

Dr Núñez, trained as a physician and surgeon and has a master’s degree in International Public Health from the University of Washington.

 

Judicial reform for the protection of adolescent women in juvenile detention

Towards treatments to cure HIV infection: developing to tools for HIV latency reversal and clearance

 

David Margolis, MD is the director of the UNC HIV Cure Center, and aSarah Graham Keenan Distinguished Professor of Medicine, Microbiology & Immunology, and Epidemiology at the University of North Carolina at Chapel Hill.  An HIV clinician and translational scientist, his laboratory studies host-HIV interactions, and is developing approaches that seek to eradicate persistent HIV infection. He isthe principal investigator of the NIH-sponsored Collaboratory of AIDS Researchers for Eradication (CARE; http://www.delaneycare.org).

The therapeutic value of cannabis in HIV management

Marcus Day, Doctor of Science (D.Sc.) Geography, Buxton University) is the Director of the Caribbean Drug & Alcohol Research Institute based in Castries, Saint Lucia. Under his leadership for the past 14 years, CDARI has studied the overlap between drug use and HIV infection on vulnerable populations

 Dr Day is a long time advocate for the use of therapeutic cannabis and general drug policy reform in the Caribbean. He has written extensively on the application of the principles of harm reduction in the non-injecting environments of LAC and was l;ead author on a UNODC guidance tool on Stimulant Use and HIV. He is currently servicing as guest editor for a special edition of Drugs and Alcohol Today entitled ChemSex and the Right to Pleasure.

 He is a founding member of the Caribbean Vulnerable Communities and the past Co-Chair of the CVC Board of Governors.  He has served as the technical advisor for the Caribbean regional prison superintendents association and technical advisor under the 9thEDF to CARICOM for HIV and Dug use. Dr Day was a member of the core group of the UN Reference group on Injecting Drugs and HIV and a leading expert on sexual transmission of HIV associated with non-injecting crack cocaine use.

 He has served as principal investigator on research projects:

  • Youth, Crime and Violence in Saint Lucia
  • Crack cocaine and HIV Risk Street Drug Users in Saint Lucia and
  • Drug use and HIV Risk Behaviours among Caribbean MSM community.

Dr Day is the co-editor of the 2001 volume on drug use in the Caribbean entitled “Caribbean Drugs, from Criminalisation to Harm Reduction (Zed Publishing London, 2004), the 2005 Manual of Alternative Sentencing in the Caribbean and a contributor in the 2009 Ian Randal published volume entitled Sexuality, Social Exclusion and Human Rights with an article entitled Drugs Obscure the Human Rights Issues for Drug Users Are Demons and Jumbies Rights Holders?

 

  1. Test, Treat, Defeat in Caribbean Advocacy

  2. Caribbean regional strategic framework: beyond 2018

Mr. Dereck Springer, Master of Public Health, Director of the Pan Caribbean Partnership Against HIV and AIDS, PANCAP, is a public health practitioner and behavioural specialist with 24 years of experience in the health sector, primarily in HIV and mental health. He began his public health career as a Volunteer Counsellor at the Genito-Urinary Medicine Clinic, Guyana.  His extensive experience in policy, management and programme implementation at the national and regional levels has been facilitated by his work with civil society, government, regional and international technical assistance agencies.

He has previously been Senior Advisor for the US Centers for Disease Control and Prevention Global AIDS Program Guyana, UNAIDS’ Focal Point in Guyana and National Coordinator of Voluntary Counselling and Testing for the Ministry of Health. He is the former Chair of the Implementer Group of the Global Fund Board and the Communications and Governance Focal Point for the Latin America and the Caribbean delegation to the Global Fund Board.

 

Biological mechanisms underlying HIV-1 eradication: lessons learnt from the ‘Mississippi baby’

Successes and challenges of implementing juvenile detention reforms: The Grenada experience

GHESKIO’S Maternal and Child Health and Nutrition Centre

PreP in the Caribbean: A progress report